Related Experiment Video
Updated: May 9, 2026
07:12
Clinical Efficacy of an Innovative Multidimensional Traction Therapy in Moderate Adolescent Idiopathic Scoliosis
Published on: February 10, 2026
Challenges and opportunities in SLE clinical trials
1Unit for Clinical Therapy Research, Inflammatory Diseases, The Karolinska Institute, Stockholm, Sweden. ronald.van.vollenhoven@ki.se
Current Opinion in Rheumatology
|August 7, 2013
Summary
Recent clinical trials in systemic lupus erythematosus (SLE) show success, particularly with belimumab, highlighting the importance of large patient numbers and flexible trial designs for future SLE research.
Area of Science:
- Rheumatology
- Clinical Trial Design
- Immunology
Background:
- Systemic lupus erythematosus (SLE) is a complex autoimmune disease.
- Clinical trials are crucial for developing new SLE treatments.
- Past trials have faced challenges, leading to limited success.
Purpose of the Study:
- To review recent clinical trials in SLE.
- To identify lessons from both failed and successful trials.
- To guide future clinical trial design in SLE.
Main Methods:
- Analysis of recent phase III randomized controlled trials (RCTs) in SLE.
- Examination of trial characteristics, including patient numbers and design flexibility.
- Review of posthoc analyses from previously failed trials.
Main Results:
- Several recent SLE clinical trials have demonstrated success.
- Belimumab achieved primary endpoints in large RCTs, leading to regulatory approval.
- Mycophenolate mofetil showed clinical benefit in lupus nephritis, despite nominal trial failure.
- Posthoc analyses suggest design modifications could alter outcomes for trials with abatacept and rituximab.
Conclusions:
- Improved understanding of SLE clinical trial design features is essential.
- Robust outcome measures are critical for trial success.
- Effective design and conduct of future SLE trials can be achieved through informed strategies.
Related Concept Videos
01:16Clinical Trials
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
01:11Clinical Trials: Overview
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
01:28Preclinical Development: Overview
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
01:23Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
01:26Drug Discovery: Overview
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
01:26Drug Administration and Therapy Phases: Overview
Drugs, the chemical agents used in diagnosing, treating, or preventing diseases, undergo a four-phase process of development: pharmaceutic, pharmacokinetics, pharmacodynamics, and therapeutic.
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...